Cutting edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule

Journal of Immunology

Volumn 171, Issue 2, 2003, Pages 538-541

  Hill, Jonathan A ^a,b   Southwood, Scott ^c   Sette, Alessandro ^d   Jevnikar, Anthony M ^a,b   Bell, David A ^a,b   Cairns, Ewa ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c Epimmune   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CITRULLINE; EPITOPE; HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0038107566     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.2.538     Document Type: Article

References (24)

1. Gregersen, P. K., J. Silver, and R. J. Winchester. 1987. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Archritis Rheum. 30:1205.
2. Reviron, D., A. Perdriger, E. Toussirot, D. Wendling, N. Balandraud, S. Guis, G. Semana, P. Tiberghien, P. Mercier, and J. Roudier. 2001. Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum. 44:535.
3. van Venrooij, W. J., and G. J. Pruijn. 2000. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2:249.
4. Zhou, Z., and H. A. Menard. 2002. Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis? Curr. Opin. Rheumatol. 14:250.
5. Menard, H. A., E. Lapointe, M. D. Rochdi, and Z. J. Zhou. 2000. Insights into rheumatoid arthritis derived from the Sa immune system. Arthritis Res. 2:429.
6. Goldbach-Mansky, R., J. Lee, A. McCoy, J. Hoxworth, C. Yarboro, J. S. Smolen, G. Steiner, A. Rosen, C. Zhang, H. A. Menard, et al. 2000. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2:236
7. Bas, S., T. V. Perneger, E. Mikhnevitch, M. Seitz, J. M. Tiercy, P. Roux-Lombard, and P. A. Guerne. 2000. Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis. Rheumatology (Oxford) 39:1082.
8. Ito, K., H. J. Bian, M. Molina, J. Han, J. Magram, E. Saar, C. Belunis, D. R. Bolin, R. Arceo, R. Campbell, et al. 1996. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183:2635.
9. Hill, J. A., D. Wang, A. M. Jevnikar, E. Cairns, and D. A. Bell. 2002. The relationship between predicted peptide-MHC class II affinity and T cell activation in a HLA-DRβ1*0401 MHC class II mouse model. Arthritis Res. Ther. 5:R40.
10. Hammer, J., E. Bono, F. Gallazzi, C. Belunis, Z. Nagy, and F. Sinigaglia. 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353.
11. Andersson, E. C., B. E. Hansen, H. Jacobsen, L. S. Madsen, C. B. Andersen, J. Engberg, J. B. Rothbard, G. S. McDevitt, V. Malmstrom, R. Holmdahl, et al. 1998. Definition of MHC and T cell receptor contacts in the HLA-DR4-restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc. Natl. Acad. Sci. USA 95:7574.
12. Southwood, S., J. Sidney, A. Kondo, M. F. del Guercio, E. Appella, S. Hoffman, R. T. Kubo, R. W. Chesnut, H. M. Grey, and A. Sette. 1998. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160:3363.
13. Dessen, A., C. M. Lawrence, S. Cupo, D. M. Zaller, and D. C. Wiley. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7:473.
14. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Narure 368:215.
15. Hammer, J., F. Gallazzi, E. Bono, R. W. Karr, J. Guenot, P. Valsasnini, Z. A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847.
16. Sturniolo, T., E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigaglia, and J. Hammer. 1999. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17:555.
17. Peterson, D. A., R. J. DiPaolo, O. Kanagawa, and E. R. Unanue. 1999. Cutting edge: negative selection of immature thymocytes by a few peptide-MHC complexes: differential sensitivity of immature and mature T cells. J. Immunol. 162:3117.
18. DiPaolo, R. J., and E. R. Unanue. 2001. The level ofpeptide-MHC complex determines the susceptibility to autoimmune diabetes: studies in HEL transgenic mice. Eur. J. Immunol. 31:3453.
19. Yagi, J., and C. A. Janeway. 1990. Ligand thresholds at different stages of T cell development. Int. Immunol. 2:83.
20. Quarsten, H., O. Molberg, L. Fugger, S. N. McAdam, and L. M. Sollid. 1999. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur. J. Immunol. 29:2506.
21. Ghosh, P., M, Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
22. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301.
23. Masson-Bessiere, C., M. Sebbag, E. Girbal-Neuhauser, L. Nogueira, C. Vincent, T. Senshu, and G. Serre. 2001. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin. J. Immunol. 166:4177.
24. Goronzy, J. J., A. Zettl, and C. M. Weyand. 1998. T cell receptor repertoire in rheumatoid atthritis. Int. Rev. Immunol. 17:339.